Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 10/20 | 0.63 |
| ▸ | FNTB | P49356 | 10/20 | 0.63 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.57 |
| ▸ | BACE1 | P56817 | 4/20 | 0.54 |
| ▸ | CTSD | P07339 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6810437 | 1.00 | FNTA (0.63) | FNTAFNTBPGGT1BBACE1CTSD | |
| SCHEMBL7069273 | 0.97 | FNTA (0.64) | FNTAFNTBPGGT1BBACE1CTSD | |
| SCHEMBL6814564 | 0.94 | FNTA (0.58) | FNTAFNTBPGGT1B | |
| SCHEMBL6814551 | 0.94 | FNTA (0.58) | FNTAFNTBPGGT1B | |
| SCHEMBL6809801 | 0.93 | BACE1 (0.56) | FNTAFNTBPGGT1BBACE1 | |
| SCHEMBL6809794 | 0.93 | BACE1 (0.56) | FNTAFNTBPGGT1BBACE1 | |
| SCHEMBL7074831 | 0.90 | FNTA (0.58) | FNTAFNTBPGGT1BBACE1 | |
| SCHEMBL7074828 | 0.90 | FNTA (0.58) | FNTAFNTBPGGT1BBACE1 | |
| SCHEMBL12519269 | 0.89 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL8519036 | 0.89 | FNTA (0.78) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040018983-A1 | Antifungal compositions | ACHILLION PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| US-20040018983-A1 | Antifungal compositions | ACHILLION PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | disclosed |
| WO-2003055448-A2 | ANTIFUNGAL COMPOSITIONS | ACHILLION PHARMACEUTICALS, INC. (US) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018983-A1 | Antifungal compositions | CNBP, ERG28, AEBP2 | FNTA 1193/4885FNTB 527/4885PGGT1B 1559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.